The SEC61G-UBE3C-PGAM1 axis driving glycolytic metabolic reprogramming observed in this study aligns with these findings, further emphasizing the central role of metabolic regulation in NSCLC brain metastases. This evidence concerns the gene SEC61G and non-small cell lung carcinoma.